I don't even understand what you are saying NZ.
No one but you is talking about Zolvix.
The discussion related to the same API being available on market concurrently a) in human tabs to treat ND for north of $100,000 per annum AND b) in dog tabs to treat canine lymphoma (this is what was used in the trial - tabs, not Zolvix) for a few hundred bucks per month (the price point for dog owners looking to treat their pet). It's a commercialisation nightmare.
Is this really so difficult to grasp?
Cheers
Densy
I don't even understand what you are saying NZ.No one but you is...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.0¢ | $191.1K | 906.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9563 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.000 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.0¢ | 22.5¢ | 20.5¢ | 533029 | ||
| Last updated 15.54pm 03/05/2024 ? | |||||
| PAA (ASX) Chart |